Greetings, and welcome to Where Food Comes From Second Quarter Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. Please note this conference call is being recorded. I would now like to turn the call over to your host, Mr. Jay Pfeiffer, Investor Relations. Thank you. You may begin.

Good morning or good afternoon and welcome to Where Food Comes From second quarter earnings call. Joining me on the call today are John Saunders, CEO; Leann Saunders, President; and Dannette Henning, CFO. During this call, we will make forward-looking statements based on current expectations, estimates and projections that are subject to risk. Statements about future revenue, expenses, profitability, cash, growth strategy, new customer wins, business opportunities, market acceptance of our products and services and potential acquisitions are forward-looking statements. Listeners should not place undue reliance on these statements as there are many factors that could cause actual results to differ materially from our forward-looking statements. We encourage you to review our publicly filed documents as well as our news releases and website for more information about the company. Today, we will also discuss EBITDA and adjusted EBITDA, which are non-GAAP financial measures, provided as a complement to the results provided in accordance with GAAP. We use and believe investors benefit from the presentation of EBITDA and adjusted EBITDA in evaluating our operating performance as it provides an additional tool to compare our performance on a consistent basis by removing the impact of certain items that management believes do not directly reflect our operations. I'll now turn the call over to John Saunders, Chairman and CEO. John?

Good morning and thanks for joining the call today. Earlier this morning, we released our Q2 financial results and I'm pleased to say that we are more than holding our own given the pervasive and continuing negative effects the pandemic is having on the food supply chain in general and our customers in specific. Revenue in the second quarter was $4.4 million, which was down only 10% year-over-year. Our six-month revenue was $8.3 million down nearly 6% from the same period last year. As I said these relatively positive results come at a time when many of our customers across the food supply chain are in great difficulty. The nation's largest protein processors are struggling to remain consistently operational suffering from intermittent slowdowns and plant closures that are creating havoc up and down the supply chain. Our ranch and farm customers particularly in the area of pork, poultry, dairy, and egg production where facilities are more enclosed relative to cattle ranches have severely curtailed onsite audits for the time being. So in this context, we think our top-line is pretty good. For those of you who have followed us for a while, you know that one of my recurring themes when I talk to investors is the depth and breadth of our solutions portfolio. For whatever reason, it seems our industry is subject to more ups and downs and anomalous events than other industries. And through the years as we've grown and diversified our services, we've seen certain parts of our businesses pick up the slack for other parts. Avian and swine flu are just two examples of that. Although both had devastating impacts on our poultry and swine business in given years, our overall business continue to grow and prosper because of the diversity of our revenue streams. So…

At this time, we'll be conducting a question-and-answer session. [Operator Instructions]. Our first question comes from Terry Thompson, a Private Investor. Please proceed with your question.

Hello, John. Hello to all in Castle Rock looks like things work out pretty good considering everything that's going on, all the disruptions. My question is concerning the trade issues vis-à-vis China, primarily present view of that, and any predictions on what may be coming in the future?

Hey Terry, I'm going to let Leann answer that question.

Hi, Terry.

Hi, Leann.

So trying to predict anything relative to trade agreements right now is a little bit challenging. So I won't try to do that. But thus far everything relative to kind of the protein movement quotas that are existing all seem to be holding. So we haven't seen any sort of disruption outside of when you had containers out on water because of COVID held up, where you just couldn't get meat through the channels initially, those channels have seemed to have opened up and product seems to be flowing relatively well, Terry given all the circumstances. And we haven't really seen any sort of disruption yet even with all of the discussion and rhetoric in the media

Great. Well that's good news, ma'am, in these uncertain times. Thanks again and give my best everyone up there.

Thanks, Terry.

[Operator Instructions]. Our next question comes from Chris Brown, a Private Investor. Please proceed with your question.

Thank you. Last quarter, I asked a little bit about the credit exposure you have to your customers and how they're doing given the COVID disruption. Can you just talk a little bit about that? And then my second question was just, I noticed you guys added some debt to your balance sheet, could you describe what that was and the purpose? Thank you.

Sure. Yes, the first question is no, we haven't seen any change in our payment by producers. In fact, I think in certain areas, specifically our organic business has improved, if you can believe it. And there's just been such a demand for organic products. I think our producers are ready to make sure that they're all up to speed on stuff. So it's been really positive. The debt question I will let Dannette answer specifically, but I believe it's related to our PPP loan.

Yes, it is related to the PPP loan. And it was just a great opportunity that the FDA was offering companies; it was during the time we didn't know what our performance was going to look like at that very moment when they made the offer. And so we decided that it would be beneficial to our business and it has helped. We have not received any notification of whether or not it will be fully forgiven. However, we anticipate that a significant portion of it will be forgiven. FDA is still trying to finalize those rules on forgiveness.

And what was the total size of the loans?

It was just a little bit over $1 million.

Great. Hey thank you very much and thank you for the call today.

Sure. Thank you.

Thanks, Chris.

Our next question comes from Alex Team with First Ballantyne. Please proceed with your question.

Hi, guys, congrats on the great quarter. Can you talk a little bit of more about your SG&A reduction and if that will be a continuing trend? Or is this just for this quarter?

I'll let again Dannette answer the specifics. But I tell you I think the -- there's been such a reduction in travel, marketing costs. We were -- we were attending two dozen different conferences over the course of the year. So we've had a lot of changes there, are because we're doing a certain degree of remote audits, there's a reduction there as well. So it's been a real -- it's been a real change for us as a verification company. I think it offers us benefit moving forward. To answer your question about will it always be this way? I think we'll probably again; this has been the worst quarter for everybody as because just there's been such a decline in business and travel. I don't see it staying consistently that way. But I do see there being a change in our business model moving forward, where we incorporate technology and potentially remote auditing as a bigger part of our services. So Dannette, I'll let you give the specifics.

Yes, what John said was exactly right. Our marketing and our travel has decreased, I don't know how long it'll stay at that level. Obviously as we start to return to business as it's going to look out in the future, it's hard to say whether or not that will continue at that level. But I think we will continue to invest in our marketing. And there will have to be a little bit more traveling pickup as -- as well as we go in the future. Thank you.

[Operator Instructions]. There are no further questions. At this time, I'd like to turn the call back over to John Saunders for closing comments.

Well, we had great group out today. We really appreciate everybody's participation, and we'll talk to you in 90 days. Have a great day.

This concludes today's conference. You may disconnect your lines at this time. And we thank you for your participation.